Coronary heart disease (CHD), predominantly due to myocardial infarction (MI), is the number one cause of death in the United Kingdom [1]. However, one of its most common initial manifestations, angina, remains as of yet understudied and its burden may be underappreciated. This is partly because diagnosis of stable angina pectoris is based solely on the characterization of the pain as elicited by the doctor. Many patients with typical symptoms of stable angina are not diagnosed as angina and factors such as sex, ethnicity and age may influence the physician’s final recommendations for diagnostic testing such as coronary angiography.
Optimising Management of Angina (OMA) is a cluster randomized controlled trial of a multi-faceted decision support and educational intervention within chest pain clinics across England. OMA looks at ways of improving the care of people suffering with angina as well as exploring the reasons why treatment received varies.
Contents |
OMA is a collaboration between:
OMA is funded by the NHS National Institute of Health Research (NIHR)
[Optimising Management of Angina home page http://omastudy.org.uk/]